IR-Med's Potential for Profitable Growth in Coming Years Supports Price Target of $3.00 - IR-Med (OTC:IRME)
By Thomas Kerr, CFA
Source: benzinga.com
Stay updated with breaking news from Clinical Efficacy Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.